On December 19, CSPC PHARMA (01093.HK) spent 29.294 million HKD to repurchase 6.15 million shares.

Gelonghui reported on December 19 that CSPC PHARMA (01093.HK) announced that on December 19, 2024, it spent 29.294 million Hong Kong dollars to repurchase 6.15 million shares, with the repurchase price ranging from 4.72 to 4.79 Hong Kong dollars per share.

Gelonghui Finance04:14 ET

CSPC PHARMA (01093.HK) spent 29.27 million HKD to repurchase 6.2 million shares on December 18.

Gelonghui, December 18: CSPC PHARMA (01093.HK) announced that on December 18, it spent 29.27 million Hong Kong dollars to repurchase 6.2 million shares.

Gelonghui FinanceDec 18 04:53 ET

CSPC PHARMA (01093.HK) spent HKD 29.325 million on December 17 to repurchase 6.3 million shares.

Gelonghui, December 17 - CSPC PHARMA (01093.HK) announced that on December 17, 2024, it spent HKD 29.325 million to repurchase 6.3 million shares, with a repurchase price of HKD 4.61-4.7 per share.

Gelonghui FinanceDec 17 04:51 ET

Statistics on Hong Kong Stock Repurchases | December 17

Hong Kong stock repurchase Statistics | December 17

Zhitong FinanceDec 16 20:10 ET

Notice highlights | China Eastern Airlines Corporation's passenger traffic increased by about 20% in November; CTIHK expects an annual Net income growth of no less than 30%.

In November, CHINA SOUTH AIR's passenger capacity input rose by 7.18% year-on-year; passenger turnover increased by 15.17% year-on-year; China Eastern Airlines' passenger capacity input increased by 9.19% year-on-year; passenger turnover increased by 20.86% year-on-year.

cls.cnDec 16 19:17 ET

On December 16, CSPC PHARMA (01093.HK) spent HKD 29.357 million to buy back 6.3 million shares.

On December 16, Gelonghui announced that CSPC PHARMA (01093.HK) will spend HKD 29.357 million on December 16, 2024, to repurchase 6.3 million shares, with a repurchase price ranging from HKD 4.62 to HKD 4.79 per share.

Gelonghui FinanceDec 16 04:30 ET